Slovak Radiological Society, Slovakia

Similar documents
The Centre for Disease Prevention and Control, Latvia

National Center for Tumor Diseases (NCT) Heidelberg, Germany

INSTITUTE OF CHILD HEALTH, Greece

Central Manchester University Hospitals NHS Foundation Trust, UK

Hospital Carlos Haya. Malaga, Spain

Ministry for Health, the Elderly and Community Care, Malta

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

European Society of Cardiology, France

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Department of Medical Genetics, Medical School, University of Athens, Greece

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

Cystic Fibrosis Europe (CFE), Germany

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

VSOP, Lupus Netherlands

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

ERN board of Member States

European Haemophilia Consortium

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Introduction to ibmg. Marco Varkevisser Director of Education

ERN Assessment Manual for Applicants

Spreading Excellence and Widening Participation in Horizon 2020

Call for Nominations. CARLOS V European Award

Jean Monnet Activities in Slovakia

Do terms like FP6, CORDIS, Specific Programme, Call for

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

FP7: Marie Curie Actions

Implementation and adaptation of the European Guidelines into the Romanian public hospitals; the medical physicist role in the Romanian context

2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois

A European workforce for call centre services. Construction industry recruits abroad

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

Communications Review of the EEA and Norway Grants Final Report

Dissemination and Communication Strategy Plan

ERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation

Terms of reference. for the Council of European Specialist Medical Assessment

European Funding Opportunities in the field of Language Teaching and Learning

European Quality Assurance Scheme for Breast Cancer Services

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

Jean Monnet support to associations

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

International dimension of Higher Education 27/06/2015

European Reference Networks: strategic value for the Member States. Perspective of France

Copernicus Incubation Programme

European Reference Networks (ERN) Guide for patient advocates

Study in Brussels. The heart of Europe

Council, 25 September 2014

Erasmus+ Programme Jean Monnet Activities. Snejina Nikolova Education, Audiovisual and Culture Executive Agency (EACEA)

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Job Description. Clinical Nurse Specialist in Breast care. An overview of Breast Cancer Services at the UPMC Beacon Hospital.

S. Tziaferi. President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

The results will be published on the SCoR website. Individual responses will not be identifiable.

Call for proposals EAC / S01 / Pilot project for the development of Sector Skills Alliances. Frequently asked questions (updated on 22/06/2012)

Erasmus Mundus José Gutiérrez Fernández Erasmus Mundus Programme Coordinator EACEA

European Investment Advisory Hub

Roma inclusion in the EEA and Norway Grants

Consultation: Transformation Health and Care in the Digital Single

International Credit Mobility Call for Proposals 2018

Brokerage for the first ProSafe Call Dina Carrilho Call Secretariat Foundation for Science and Technology (FCT), Portugal

EUROPEAN SOCIETY OF COLOPROCTOLOGY

Education and Training Committee, 5 June 2014

Annex 3 Information and Communication Requirements EEA and Norway Grants

H2020 Work Programme : Spreading Excellence and Widening Participation Call: H2020-TWINN-2015: Twinning Frequently Asked Questions (FAQ)

Mobilnost istraživača u Hrvastkoj. Prof.dr.sc. Neven Duić Euraxess Croatia Nacionalni koordinator hrvatske mreže mobilnosti

European Solidarity Corps

EIT HEALTH WILD CARD PROJECTS CALL FOR APPLICATIONS 2018

Supportive Care Roundtable

Simona Bovha, CPCM European Investment Bank. European Investment Advisory Hub

Call text. The Programme supports 6 fellows working on projects of a duration up to 36 months recruited in the current call for proposals.

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

Section Items to check Yes No. /letter from Centre Director (internal only, not sent to ARC)

Assessment of Erasmus+ Sports

ANNEX I TO VIII ANNEX I. Health Programme Work Programme for 2017

Young scientist competition 2016

HERE Annual Conference: EU and its Neighbours: Higher Education Policy and Cooperation

Call for the expression of interest Selection of six model demonstrator regions to receive advisory support from the European Cluster Observatory

QUICK REFERENCE TO CALDICOTT & THE DATA PROTECTION ACT 1998 PRINCIPLES

TUITION FEE GUIDANCE FOR ERASMUS+ EXCHANGE STUDENTS Academic Year

Transforming Cancer Services In South East Wales

Programme Officer International Development

Erasmus+ Benefits for Erasmus+ Students

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Innovation and research priorities of the EEA and Norway Grants

Document: Report on the work of the High Level Group in 2006

The ERC funding strategy

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Involvement of ESF and EMRC in Clinical Trials Wellcome Trust, London, 16 March 2010 by Dr. Maria Manuela Nogueira ESF Science Officer.

FP7 IDEAS The European Research Council

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

CLOSING DATE: 13 th December 2013

Transcription:

Slovak Radiological Society, Slovakia 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Academic/public health and healthcare specialised institution/organisation (e.g. Institutes and University Departments of Public Health, Quality, Healthcare, Clinical Excellence) Please indicate level: National level organisation Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: Slovak Radiological Society 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: SK 1. Please indicate the number of EU Member States and EEA countries (Norway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1 1.5 If need be, can we contact you by e-mail to obtain further information on your submission? 1.5.1 Please provide an e-mail address where we can contact you: bilicky@pe.unb.sk, secretary - gabcap@gmail.com 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): prof. Jozef Bilicky - bilicky@pe.unb.sk contact only by e-mail please secretary Dr. Gabriela Pavlendova - gabcap@gmail.com

1.7 Please provide additional contact details if needed: 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) High Highly specialised healthcare provision Professional performance, clinical practice, quality and safety of specialized healthcare Assessment/evaluation/certification of clinical practice and healthcare providers 2.2.1. Space for further comments: Especially oncology and mammology 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2.3.1 Space for further comments: 2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Somewhat High tech diagnostic and treatment services (radiology, nuclear medecine, electrophysiology, radiotherapy etc.) Please specify: 2.5. Has your organisation/centre been directly involved in the design Frequently or assessment of professional standards and criteria related with highly specialised healthcare? radiodiagnostic,especially oncology,cardiovascular

2.5.1 Please describe your role in such actions/projects: coding for health insurancies Certification for mammodiagnostics in radiology and interventional radiology-guidelines and training preparation, educational and legal process, evaluation of candidates 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? 2.7.1 Space for further comments: We have the standards for Certification in Mammodiagnostics in Radiology but only in slovak language - for further information please contact Associate professor Viera Lehotska, PhD. - vlehot@ousa.sk 2.13. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments: 2.15. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, 5 = very interested) 2.15.1 Space for further comments: 3. Proposed criteria for ERN (scope, general and specific criteria)

3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 5 3.1.1.1. Complexity of the diagnosis and treatment 5 3.1.1.2. High cost of treatment and resources 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 5 3.1.2.1. Rare expertise/need of concentration of cases 3 3.1.2.2. Low prevalence/incidence/number of cases 3 3.1.2.3. Evaluated experiences of Member States 3.1.3. Based on high-quality, accessible and cost-effective healthcare 5 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 5 3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? 5 No 3.1.5. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria?

3.1.5.1 Explain your proposal in free text: carcinoma mammae 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 3.2.3. Patient care, clinical tools and health technology assessment 5 3.2.. Quality, patient safety and evaluation framework policies 5 3.2.5. Business continuity, contingency planning and response capacity 3 3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training 3 3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 5 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: No 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 5 3.3.2. Specific resources and organisation: 3

3.3.2.1. Human resources 5 3.3.2.2. Team/centre organisation 5 3.3.2.3. Structural conditions 3.3.2.. Specific equipment 5 3.3.2.5. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients 3.3.5. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 2 5 3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: I think the issue was adequately addressed by your questionnaire. No